{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:11:18Z","timestamp":1792033878776,"version":"4.4.0"},"reference-count":86,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Council"},{"name":"Wellcome Trust Investigator","award":["109915\/Z\/15\/Z"],"award-info":[{"award-number":["109915\/Z\/15\/Z"]}]},{"name":"Wellcome Trust Investigator","award":["MR\/N025431\/1"],"award-info":[{"award-number":["MR\/N025431\/1"]}]},{"name":"Wellcome Trust Investigator","award":["MR\/V009346\/1"],"award-info":[{"award-number":["MR\/V009346\/1"]}]},{"name":"European Research Council","award":["309548"],"award-info":[{"award-number":["309548"]}]},{"DOI":"10.13039\/100010897","name":"Newton Fund","doi-asserted-by":"crossref","award":["MR\/N027302\/1"],"award-info":[{"award-number":["MR\/N027302\/1"]}],"id":[{"id":"10.13039\/100010897","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Addenbrookes Charitable Trust","award":["G100142"],"award-info":[{"award-number":["G100142"]}]},{"DOI":"10.13039\/501100004282","name":"Evelyn Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004282","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Stoneygate Trust"},{"DOI":"10.13039\/501100022186","name":"Lily Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022186","id-type":"DOI","asserted-by":"crossref"}]},{"name":"International Centre for Genomic Medicine in Neuromuscular Diseases","award":["MR\/S005021\/1"],"award-info":[{"award-number":["MR\/S005021\/1"]}]},{"name":"NIHR Cambridge Biomedical Research Centre","award":["1215-20014"],"award-info":[{"award-number":["1215-20014"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["FDN-167281"],"award-info":[{"award-number":["FDN-167281"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canadian Institutes of Health Research and Muscular Dystrophy Canada"},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"crossref","award":["JELF 38412"],"award-info":[{"award-number":["JELF 38412"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"crossref","award":["950-232279"],"award-info":[{"award-number":["950-232279"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002721","name":"Charcot-Marie-Tooth Association","doi-asserted-by":"crossref","award":["603003"],"award-info":[{"award-number":["603003"]}],"id":[{"id":"10.13039\/100002721","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CMT Research Foundation"},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","award":["G041416N"],"award-info":[{"award-number":["G041416N"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007660","name":"University of Antwerp","doi-asserted-by":"crossref","award":["38694"],"award-info":[{"award-number":["38694"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"crossref","award":["577497"],"award-info":[{"award-number":["577497"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100022601","name":"Medical Foundation Queen Elisabeth","doi-asserted-by":"crossref","award":["779257"],"award-info":[{"award-number":["779257"]}],"id":[{"id":"10.13039\/501100022601","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["F31 NS100328"],"award-info":[{"award-number":["F31 NS100328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R37 NS054154"],"award-info":[{"award-number":["R37 NS054154"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Genomics Technology Platform","award":["264PRO"],"award-info":[{"award-number":["264PRO"]}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018851","name":"Warren Y. Soper Charitable Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018851","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018765","name":"Alvin Segal Family Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018765","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["075-10-2019-083"],"award-info":[{"award-number":["075-10-2019-083"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Molecular markers scalable for clinical use are critical for the development of effective treatments and the design of clinical trials. Here, we identify proteins in sera of patients and mouse models with Charcot-Marie-Tooth disease (CMT) with characteristics that make them suitable as biomarkers in clinical practice and therapeutic trials.<\/jats:p>\n                  <jats:p>We collected serum from mouse models of CMT1A (C61 het), CMT2D (GarsC201R, GarsP278KY), CMT1X (Gjb1-null), CMT2L (Hspb8K141N) and from CMT patients with genotypes including CMT1A (PMP22d), CMT2D (GARS), CMT2N (AARS) and other rare genetic forms of CMT. The severity of neuropathy in the patients was assessed by the CMT Neuropathy Examination Score (CMTES). We performed multitargeted proteomics on both sample sets to identify proteins elevated across multiple mouse models and CMT patients. Selected proteins and additional potential biomarkers, such as growth differentiation factor 15 (GDF15) and cell free mitochondrial DNA, were validated by ELISA and quantitative PCR, respectively.<\/jats:p>\n                  <jats:p>We propose that neural cell adhesion molecule 1 (NCAM1) is a candidate biomarker for CMT, as it was elevated in Gjb1-null, Hspb8K141N, GarsC201R and GarsP278KY mice as well as in patients with both demyelinating (CMT1A) and axonal (CMT2D, CMT2N) forms of CMT. We show that NCAM1 may reflect disease severity, demonstrated by a progressive increase in mouse models with time and a significant positive correlation with CMTES neuropathy severity in patients. The increase in NCAM1 may reflect muscle regeneration triggered by denervation, which could potentially track disease progression or the effect of treatments.<\/jats:p>\n                  <jats:p>We found that member proteins of the complement system were elevated in Gjb1-null and Hspb8K141N mouse models as well as in patients with both demyelinating and axonal CMT, indicating possible complement activation at the impaired nerve terminals. However, complement proteins did not correlate with the severity of neuropathy measured on the CMTES scale. Although the complement system does not seem to be a prognostic biomarker, we do show complement elevation to be a common disease feature of CMT, which may be of interest as a therapeutic target.<\/jats:p>\n                  <jats:p>We also identify serum GDF15 as a highly sensitive diagnostic biomarker, which was elevated in all CMT genotypes as well as in Hspb8K141N, Gjb1-null, GarsC201R and GarsP278KY mouse models. Although we cannot fully explain its origin, it may reflect increased stress response or metabolic disturbances in CMT. Further large and longitudinal patient studies should be performed to establish the value of these proteins as diagnostic and prognostic molecular biomarkers for CMT.<\/jats:p>","DOI":"10.1093\/brain\/awac055","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T15:13:19Z","timestamp":1644419599000},"page":"3999-4015","source":"Crossref","is-referenced-by-count":44,"title":["NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice"],"prefix":"10.1093","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3903-1299","authenticated-orcid":false,"given":"Matthew J","family":"Jennings","sequence":"first","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Kagiava","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Neuromuscular Disorders Centre, The Cyprus Institute of Neurology and Genetics , Nicosia , Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Vendredy","sequence":"additional","affiliation":[{"name":"Peripheral Neuropathy Research Group, Department of Biomedical Sciences, Institute Born Bunge, University of Antwerp , Antwerp , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L","family":"Spaulding","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory , Bar Harbor, ME , USA"},{"name":"Graduate School of Biomedical Sciences and Engineering, University of Maine , Orono, ME 04469 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-6523","authenticated-orcid":false,"given":"Marina","family":"Stavrou","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Neuromuscular Disorders Centre, The Cyprus Institute of Neurology and Genetics , Nicosia , Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisa","family":"Hathazi","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Gr\u00fcneboom","sequence":"additional","affiliation":[{"name":"Leibniz-Institut f\u00fcr Analytische Wissenschaften\u2014ISAS\u2014e.V , Dortmund , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"De Winter","sequence":"additional","affiliation":[{"name":"Peripheral Neuropathy Research Group, Department of Biomedical Sciences, Institute Born Bunge, University of Antwerp , Antwerp , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Gess","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital Aachen , Aachen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schara","sequence":"additional","affiliation":[{"name":"Centre for Neuromuscular Disorders in Children, University of Duisburg-Essen , Essen , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Pogoryelova","sequence":"additional","affiliation":[{"name":"Directorate of Neurosciences, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals, NHS Foundation Trust , Newcastle upon Tyne , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, The Ottawa Hospital, Brain and Mind Research Institute and Children\u2019s Hospital of Eastern Ontario Research Institute, University of Ottawa , Ottawa , Canada"},{"name":"Department of Neuropediatrics and Muscle Disorders, Medical Center\u2013University of Freiburg, Faculty of Medicine , Freiburg , Germany"},{"name":"CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2394-6512","authenticated-orcid":false,"given":"Christoph H","family":"Borchers","sequence":"additional","affiliation":[{"name":"Segal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University , Montreal, Quebec , Canada"},{"name":"Gerald Bronfman Department of Oncology, Jewish General Hospital, McGill University , Montreal, Quebec , Canada"},{"name":"Center for Computational and Data-Intensive Science and Engineering, Skolkovo Institute of Science and Technology , Moscow , Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Roos","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Medicine, The Ottawa Hospital, Brain and Mind Research Institute and Children\u2019s Hospital of Eastern Ontario Research Institute, University of Ottawa , Ottawa , Canada"},{"name":"Department of Neurology, Heimer Institute for Muscle Research, University Hospital Bergmannsheil, Ruhr University Bochum , Bochum , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Burgess","sequence":"additional","affiliation":[{"name":"The Jackson Laboratory , Bar Harbor, ME , USA"},{"name":"Graduate School of Biomedical Sciences and Engineering, University of Maine , Orono, ME 04469 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2162-0933","authenticated-orcid":false,"given":"Vincent","family":"Timmerman","sequence":"additional","affiliation":[{"name":"Peripheral Neuropathy Research Group, Department of Biomedical Sciences, Institute Born Bunge, University of Antwerp , Antwerp , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-8094","authenticated-orcid":false,"given":"Kleopas A","family":"Kleopa","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Neuromuscular Disorders Centre, The Cyprus Institute of Neurology and Genetics , Nicosia , Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-170X","authenticated-orcid":false,"given":"Rita","family":"Horvath","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"issue":"2","key":"2022112205321152200_awac055-B1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","article-title":"Genetic and clinical aspects of Charcot-Marie-Tooth\u2019s disease","volume":"6","author":"Skre","year":"1974","journal-title":"Clin Genet"},{"issue":"3","key":"2022112205321152200_awac055-B2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000443706","article-title":"Epidemiologic study of Charcot-Marie-Tooth disease: A systematic review","volume":"46","author":"Barreto","year":"2016","journal-title":"Neuroepidemiology"},{"issue":"8","key":"2022112205321152200_awac055-B3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","article-title":"CMT subtypes and disease burden in patients enrolled in the inherited neuropathies consortium natural history study: a cross-sectional analysis","volume":"86","author":"Fridman","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022112205321152200_awac055-B4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0092-8674(91)90613-4","article-title":"DNA duplication associated with Charcot-Marie-Tooth disease type 1A","volume":"66","author":"Lupski","year":"1991","journal-title":"Cell"},{"key":"2022112205321152200_awac055-B5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng0692-171","article-title":"The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication","volume":"1","author":"Timmerman","year":"1992","journal-title":"Nature genetics"},{"key":"2022112205321152200_awac055-B6","doi-asserted-by":"crossref","first-page":"135357","DOI":"10.1016\/j.neulet.2020.135357","article-title":"Genetic mechanisms of peripheral nerve disease","volume":"742","author":"Stavrou","year":"2021","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"2022112205321152200_awac055-B7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1385\/NMM:8:1-2:107","article-title":"Molecular genetics of X-linked Charcot-Marie-Tooth disease","volume":"8","author":"Kleopa","year":"2006","journal-title":"Neuromolecular Med"},{"issue":"9","key":"2022112205321152200_awac055-B8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.0000000000004296","article-title":"Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1)","volume":"89","author":"Panosyan","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"2022112205321152200_awac055-B9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng1727","article-title":"Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy","volume":"38","author":"Jordanova","year":"2006","journal-title":"Nat Genet"},{"issue":"12","key":"2022112205321152200_awac055-B10","first-page":"CD011952","article-title":"Ascorbic acid for the treatment of Charcot-Marie-Tooth disease","volume":"2015","author":"Gess","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2022112205321152200_awac055-B11","first-page":"19","article-title":"Phase II, randomized, placebo-controlled trial in patients with Charcot-Marie-Tooth disease type 1A","volume":"9","author":"Attarian","year":"2014","journal-title":"ClinicalTrialsgov"},{"key":"2022112205321152200_awac055-B12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3233\/JND-200546","article-title":"Targeted therapies for hereditary peripheral neuropathies: Systematic review and steps towards a \u2018treatabolome\u2019","volume":"8","author":"Jennings","year":"2020","journal-title":"J Neuromuscul Dis"},{"issue":"11","key":"2022112205321152200_awac055-B13","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.3390\/ijms22116048","article-title":"Emerging therapies for Charcot-Marie-Tooth inherited neuropathies","volume":"22","author":"Stavrou","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"15","key":"2022112205321152200_awac055-B14","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.1074\/jbc.M109.092973","article-title":"Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids","volume":"285","author":"Penno","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"2022112205321152200_awac055-B15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41588-020-0615-4","article-title":"Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes","volume":"52","author":"Cortese","year":"2020","journal-title":"Nat Genet"},{"issue":"7","key":"2022112205321152200_awac055-B16","doi-asserted-by":"crossref","first-page":"e11803","DOI":"10.15252\/emmm.201911803","article-title":"Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice","volume":"12","author":"Wilke","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"6","key":"2022112205321152200_awac055-B17","doi-asserted-by":"crossref","first-page":"e518","DOI":"10.1212\/WNL.0000000000004932","article-title":"Plasma neurofilament light chain concentration in the inherited peripheral neuropathies","volume":"90","author":"Sandelius","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"2022112205321152200_awac055-B18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/brain\/awr322","article-title":"A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients","volume":"135","author":"Fledrich","year":"2012","journal-title":"Brain"},{"issue":"6","key":"2022112205321152200_awac055-B19","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ana.25480","article-title":"Schwann cell transcript biomarkers for hereditary neuropathy skin biopsies","volume":"85","author":"Svaren","year":"2019","journal-title":"Ann Neurol"},{"issue":"1","key":"2022112205321152200_awac055-B20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/acn3.50965","article-title":"Transmembrane protease serine 5: a novel Schwann cell plasma marker for CMT1A","volume":"7","author":"Wang","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"2022112205321152200_awac055-B21","doi-asserted-by":"crossref","first-page":"e0178376","DOI":"10.1371\/journal.pone.0178376","article-title":"Plasma metabolome and skin proteins in Charcot-Marie-Tooth 1A patients","volume":"12","author":"Soldevilla","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"2022112205321152200_awac055-B22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1136\/jnnp-2017-315721","article-title":"Biomarkers predict outcome in Charcot-Marie-Tooth disease 1A","volume":"88","author":"Fledrich","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"2022112205321152200_awac055-B23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2017-317562","article-title":"PFN2 and GAMT as common molecular determinants of axonal Charcot-Marie-Tooth disease","volume":"89","author":"Juneja","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2022112205321152200_awac055-B24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-018-0802-x","article-title":"GNE myopathy: from clinics and genetics to pathology and research strategies","volume":"13","author":"Pogoryelova","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2022112205321152200_awac055-B25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.nmd.2017.07.001","article-title":"MRC centre neuromuscular biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide","volume":"27","author":"Reza","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"2022112205321152200_awac055-B26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1529-8027.2011.00350.x","article-title":"Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease","volume":"16","author":"Murphy","year":"2011","journal-title":"J Peripher Nerv Syst"},{"issue":"3","key":"2022112205321152200_awac055-B27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/hmg\/7.3.449","article-title":"Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice","volume":"7","author":"Huxley","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"3","key":"2022112205321152200_awac055-B28","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.2353\/ajpath.2010.090694","article-title":"MCP-1\/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy","volume":"176","author":"Kohl","year":"2010","journal-title":"Am J Pathol"},{"issue":"18","key":"2022112205321152200_awac055-B29","doi-asserted-by":"crossref","first-page":"9565","DOI":"10.1073\/pnas.93.18.9565","article-title":"Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice","volume":"93","author":"Nelles","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"2022112205321152200_awac055-B30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1212\/01.wnl.0000256709.08271.4d","article-title":"CMT1X phenotypes represent loss of GJB1 gene function","volume":"68","author":"Shy","year":"2007","journal-title":"Neurology"},{"key":"2022112205321152200_awac055-B31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41434-021-00250-0","article-title":"AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy","volume":"28","author":"Kagiava","year":"2021","journal-title":"Gene Ther"},{"issue":"1","key":"2022112205321152200_awac055-B32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-017-1756-0","article-title":"A knock-in\/knock-out mouse model of HSPB8-associated distal hereditary motor neuropathy and myopathy reveals toxic gain-of-function of mutant Hspb8","volume":"135","author":"Bouhy","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2022112205321152200_awac055-B33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2006.08.027","article-title":"An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model","volume":"51","author":"Seburn","year":"2006","journal-title":"Neuron"},{"issue":"7","key":"2022112205321152200_awac055-B34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1242\/dmm.002527","article-title":"An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy","volume":"2","author":"Achilli","year":"2009","journal-title":"Dis Model Mech"},{"issue":"2","key":"2022112205321152200_awac055-B35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0976-500X.72350","article-title":"Blood sample collection in small laboratory animals","volume":"1","author":"Parasuraman","year":"2010","journal-title":"J Pharmacol Pharmacother"},{"key":"2022112205321152200_awac055-B36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-4614-7209-4_4","article-title":"Development of MRM-based assays for the absolute quantitation of plasma proteins","volume":"1023","author":"Kuzyk","year":"2013","journal-title":"Methods Mol Biol"},{"key":"2022112205321152200_awac055-B37","doi-asserted-by":"crossref","first-page":"216.e7","DOI":"10.1016\/j.neurobiolaging.2015.10.033","article-title":"Reduced mitochondrial DNA copy number is a biomarker of Parkinson\u2019s disease","volume":"38","author":"Pyle","year":"2016","journal-title":"Neurobiol Aging"},{"issue":"12","key":"2022112205321152200_awac055-B38","doi-asserted-by":"crossref","first-page":"e114462","DOI":"10.1371\/journal.pone.0114462","article-title":"Accurate measurement of mitochondrial DNA deletion level and copy number differences in human skeletal muscle","volume":"9","author":"Grady","year":"2014","journal-title":"PLoS One"},{"issue":"13","key":"2022112205321152200_awac055-B39","doi-asserted-by":"crossref","first-page":"e2012898118","DOI":"10.1073\/pnas.2012898118","article-title":"CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS","volume":"118","author":"Sun","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2022112205321152200_awac055-B40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/1873-3468.12962","article-title":"The role of tRNA synthetases in neurological and neuromuscular disorders","volume":"592","author":"Boczonadi","year":"2018","journal-title":"FEBS Lett"},{"issue":"7","key":"2022112205321152200_awac055-B41","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/acn3.50828","article-title":"p75 and neural cell adhesion molecule 1 can identify pathologic Schwann cells in peripheral neuropathies","volume":"6","author":"Kim","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"2022112205321152200_awac055-B42","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1038\/s41598-021-82388-w","article-title":"Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis","volume":"11","author":"Mosleth","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"2022112205321152200_awac055-B43","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4103\/aian.AIAN_74_19","article-title":"Plasma biomarkers as potential predictors of functional dependence in daily life activities after ischemic stroke: A single center study","volume":"23","author":"Hu\u0163anu","year":"2020","journal-title":"Ann Indian Acad Neurol"},{"key":"2022112205321152200_awac055-B44","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.abb3414","article-title":"The integrated stress response contributes to tRNA synthetase-associated peripheral neuropathy","volume":"373","author":"Spaulding","year":"2021","journal-title":"Science"},{"issue":"12","key":"2022112205321152200_awac055-B45","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/s41591-019-0673-2","article-title":"Undulating changes in human plasma proteome profiles across the lifespan","volume":"25","author":"Lehallier","year":"2019","journal-title":"Nat Med"},{"key":"2022112205321152200_awac055-B46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/8904_2015_436","article-title":"Serum GDF15 levels correlate to mitochondrial disease severity and myocardial strain, but not to disease progression in adult m.3243A&gt;G Carriers","volume":"24","author":"Koene","year":"2015","journal-title":"JIMD Rep"},{"issue":"3","key":"2022112205321152200_awac055-B47","doi-asserted-by":"crossref","first-page":"e11589","DOI":"10.15252\/emmm.201911589","article-title":"Metabolic effects of bezafibrate in mitochondrial disease","volume":"12","author":"Steele","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"6","key":"2022112205321152200_awac055-B48","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/ana.24515","article-title":"Reduced cerebrospinal fluid mitochondrial DNA is a biomarker for early-stage Parkinson\u2019s disease","volume":"78","author":"Pyle","year":"2015","journal-title":"Ann Neurol"},{"key":"2022112205321152200_awac055-B49","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2016.04.016","article-title":"Plasma circulating cell-free mitochondrial DNA in the assessment of Friedreich\u2019s ataxia","volume":"365","author":"Dantham","year":"2016","journal-title":"J Neurol Sci"},{"issue":"10","key":"2022112205321152200_awac055-B50","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00109-020-01967-y","article-title":"Expanding and validating the biomarkers for mitochondrial diseases","volume":"98","author":"Maresca","year":"2020","journal-title":"J Mol Med"},{"issue":"12","key":"2022112205321152200_awac055-B51","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1523\/JNEUROSCI.17-12-04545.1997","article-title":"Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32","volume":"17","author":"Anzini","year":"1997","journal-title":"J Neurosci"},{"issue":"3","key":"2022112205321152200_awac055-B52","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neures.2005.08.006","article-title":"Specific expression of an HNK-1 carbohydrate epitope and NCAM on femoral nerve Schwann cells in mice","volume":"53","author":"Saito","year":"2005","journal-title":"Neurosci Res"},{"issue":"9","key":"2022112205321152200_awac055-B53","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1021\/acs.jproteome.8b00022","article-title":"Characterization of na\u00efve and Vitamin C-treated mouse Schwann cell line MSC80: Induction of the antioxidative thioredoxin related transmembrane protein 1","volume":"17","author":"Phan","year":"2018","journal-title":"J Proteome Res"},{"issue":"1","key":"2022112205321152200_awac055-B54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13395-016-0101-y","article-title":"Failed reinnervation in aging skeletal muscle","volume":"6","author":"Aare","year":"2016","journal-title":"Skelet Muscle"},{"issue":"3","key":"2022112205321152200_awac055-B55","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/mcne.1999.0815","article-title":"Ectopic expression of NCAM in skeletal muscle of transgenic mice results in terminal sprouting at the neuromuscular junction and altered structure but not function","volume":"15","author":"Walsh","year":"2000","journal-title":"Mol Cell Neurosci"},{"issue":"5","key":"2022112205321152200_awac055-B56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ana.410210512","article-title":"Neural cell adhesion molecule in normal, denervated, and myopathic human muscle","volume":"21","author":"Cashman","year":"1987","journal-title":"Ann Neurol"},{"issue":"1","key":"2022112205321152200_awac055-B57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-016-0538-2","article-title":"Complement activation at the motor end-plates in amyotrophic lateral sclerosis","volume":"13","author":"Bahia El Idrissi","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2022112205321152200_awac055-B58","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2011.03.011","article-title":"Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis","volume":"235","author":"Heurich","year":"2011","journal-title":"J Neuroimmunol"},{"issue":"12","key":"2022112205321152200_awac055-B59","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.3390\/ijms19124072","article-title":"Neuromuscular junction changes in a mouse model of Charcot-Marie-Tooth disease type 4C","volume":"19","author":"Cipriani","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2022112205321152200_awac055-B60","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1093\/hmg\/ddt659","article-title":"Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice","volume":"23","author":"Sleigh","year":"2014","journal-title":"Hum Mol Genet"},{"key":"2022112205321152200_awac055-B61","doi-asserted-by":"crossref","first-page":"7520","DOI":"10.1038\/ncomms8520","article-title":"Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases","volume":"6","author":"Niehues","year":"2015","journal-title":"Nat Commun"},{"key":"2022112205321152200_awac055-B62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","article-title":"The complement system: an unexpected role in synaptic pruning during development and disease","volume":"35","author":"Stephan","year":"2012","journal-title":"Annu Rev Neurosci"},{"issue":"11","key":"2022112205321152200_awac055-B63","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1523\/JNEUROSCI.1762-15.2016","article-title":"Synaptic deficits at neuromuscular junctions in two mouse models of Charcot-Marie-Tooth type 2d","volume":"36","author":"Spaulding","year":"2016","journal-title":"J Neurosci"},{"key":"2022112205321152200_awac055-B64","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3389\/fimmu.2020.00917","article-title":"Complement inhibitor therapy for myasthenia gravis","volume":"11","author":"Albazli","year":"2020","journal-title":"Front Immunol"},{"key":"2022112205321152200_awac055-B65","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2147\/ITT.S261414","article-title":"Complement inhibition for the treatment of myasthenia gravis","volume":"9","author":"Mantegazza","year":"2020","journal-title":"Immunotargets Ther"},{"issue":"6","key":"2022112205321152200_awac055-B66","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.neuron.2018.10.014","article-title":"Changes in the synaptic proteome in tauopathy and rescue of tau-induced synapse loss by C1q antibodies","volume":"100","author":"Dejanovic","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"2022112205321152200_awac055-B67","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jns.12194","article-title":"Inhibition of complement in Guillain-Barre syndrome: the ICA-GBS study","volume":"22","author":"Davidson","year":"2017","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"2022112205321152200_awac055-B68","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jimd.12307","article-title":"Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease","volume":"44","author":"Lehtonen","year":"2021","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2022112205321152200_awac055-B69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1573403X12666160111125304","article-title":"GDF 15\u2013A novel biomarker in the offing for heart failure","volume":"12","author":"George","year":"2016","journal-title":"Curr Cardiol Rev"},{"issue":"23","key":"2022112205321152200_awac055-B70","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehm465","article-title":"Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction","volume":"28","author":"Kempf","year":"2007","journal-title":"Eur Heart J"},{"key":"2022112205321152200_awac055-B71","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/jcm9051333","article-title":"Prognostic value of growth differentiation factor 15 in kidney donors and recipients","volume":"9","author":"Jehn","year":"2020","journal-title":"J Clin Med"},{"issue":"10","key":"2022112205321152200_awac055-B72","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1128\/MCB.20.10.3742-3751.2000","article-title":"Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury","volume":"20","author":"Hsiao","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2022112205321152200_awac055-B73","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5009\/gnl16049","article-title":"Growth differentiation factor 15 predicts chronic liver disease severity","volume":"11","author":"Lee","year":"2017","journal-title":"Gut Liver"},{"issue":"6","key":"2022112205321152200_awac055-B74","doi-asserted-by":"crossref","first-page":"472","DOI":"10.4093\/dmj.2014.38.6.472","article-title":"GDF15 is a novel biomarker for impaired fasting glucose","volume":"38","author":"Hong","year":"2014","journal-title":"Diabetes Metab J"},{"issue":"43","key":"2022112205321152200_awac055-B75","doi-asserted-by":"crossref","first-page":"13640","DOI":"10.1523\/JNEUROSCI.1133-09.2009","article-title":"Progressive postnatal motoneuron loss in mice lacking GDF-15","volume":"29","author":"Strelau","year":"2009","journal-title":"J Neurosci"},{"issue":"2","key":"2022112205321152200_awac055-B76","doi-asserted-by":"crossref","first-page":"e55174","DOI":"10.1371\/journal.pone.0055174","article-title":"TGF-b superfamily cytokine MIC-1\/GDF15 is a physiological appetite and body weight regulator","volume":"8","author":"Tsai","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"2022112205321152200_awac055-B77","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00441-012-1493-6","article-title":"Local substitution of GDF-15 improves axonal and sensory recovery after peripheral nerve injury","volume":"350","author":"Mensching","year":"2012","journal-title":"Cell Tissue Res"},{"issue":"2","key":"2022112205321152200_awac055-B78","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/ehf2.13176","article-title":"Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis","volume":"8","author":"Okada","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2022112205321152200_awac055-B79","doi-asserted-by":"crossref","first-page":"154966","DOI":"10.1016\/j.cyto.2019.154966","article-title":"The myokine GDF-15 is a potential biomarker for myositis and associates with the protein aggregates of sporadic inclusion body myositis","volume":"127","author":"De Paepe","year":"2020","journal-title":"Cytokine"},{"issue":"3","key":"2022112205321152200_awac055-B80","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mus.27102","article-title":"Motor axonal neuropathy associated with GNE mutations","volume":"63","author":"Grecu","year":"2021","journal-title":"Muscle Nerve"},{"issue":"5","key":"2022112205321152200_awac055-B81","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1210\/clinem\/dgz277","article-title":"GDF15 is elevated in conditions of glucocorticoid deficiency and is modulated by glucocorticoid replacement","volume":"105","author":"Melvin","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10035","key":"2022112205321152200_awac055-B82","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"2022112205321152200_awac055-B83","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1530\/EJE-09-1066","article-title":"Macrophage inhibitory cytokine-1 is increased in individuals before type 2 diabetes diagnosis but is not an independent predictor of type 2 diabetes: the Whitehall II study","volume":"162","author":"Carstensen","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2022112205321152200_awac055-B84","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/acel.12116","article-title":"Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline - the Sydney memory and aging study","volume":"12","author":"Fuchs","year":"2013","journal-title":"Aging Cell"},{"issue":"6","key":"2022112205321152200_awac055-B85","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1474-9726.2010.00629.x","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a new marker of all-cause mortality","volume":"9","author":"Wiklund","year":"2010","journal-title":"Aging Cell"},{"key":"2022112205321152200_awac055-B86","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1212\/WNL.0000000000012266","article-title":"MicroRNAs as biomarkers of Charcot-Marie-Tooth disease type 1A","volume":"97","author":"Wang","year":"2021","journal-title":"Neurology"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awac055\/45699893\/awac055.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/11\/3999\/47175148\/awac055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/11\/3999\/47175148\/awac055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T02:18:40Z","timestamp":1700187520000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/145\/11\/3999\/6527178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":86,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,2,11]]},"published-print":{"date-parts":[[2022,11,21]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awac055","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,2,11]]}}}